All Biotechnology articles

  • /web/img/field/image/sec_0.jpg
    Article

    SEC charges MiMedx Group with accounting fraud

    2019-11-27T15:23:00Z

    Biotech company MiMedx Group and three of its former top executives have been charged with defrauding investors. In response, MiMedx reshuffled its management team, including the appointment of a new general counsel and secretary.